Back
Fortune Brands Innovations Vs. Collegium Pharmaceutical Industry Stock Comparison
Sell
28
FBIN
Fortune Brands Innovations
Last Price:
$69.35
Seasonality Move:
2.16%
Sell
45
COLL
Collegium Pharmaceutical
Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
28
Fortune Brands Innovations (FBIN)
is a Sell
Is Fortune Brands Innovations a Buy, Sell or Hold?
-
The current Fortune Brands Innovations [FBIN] share price is $69.37. The Score for FBIN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
FBIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
-
The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FBIN Stock Price Chart
What is Fortune Brands Innovations's stock price today?
-
The Fortune Brands Innovations share price today is $69.37Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBIN is experiencing slight buying pressure.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $33.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.
FBIN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.49 | Sell |
| Relative Strength Index (14 RSI): | 37.02 | Sell |
| Chaikin Money Flow: | 1039402 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (68.25 - 77.13) | Sell |
| Bollinger Bands (100): | (73.61 - 86.43) | Sell |
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 66.05 | Buy |
| Chaikin Money Flow: | 1007158 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.9 - 30.94) | Buy |
| Bollinger Bands (100): | (30.52 - 37.92) | Sell |
FBIN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.42 | Buy |
| 20-day SMA: | 71.15 | Sell |
| 50-day SMA: | 75.97 | Sell |
| 200-day SMA: | 76.28 | Sell |
| 8-day EMA: | 68.84 | Buy |
| 20-day EMA: | 70.91 | Sell |
| 50-day EMA: | 74.89 | Sell |
| 200-day EMA: | 76.3 | Sell |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.45 | Buy |
| 20-day SMA: | 29.79 | Buy |
| 50-day SMA: | 30.91 | Buy |
| 200-day SMA: | 34.47 | Sell |
| 8-day EMA: | 30.02 | Buy |
| 20-day EMA: | 29.94 | Buy |
| 50-day EMA: | 31.21 | Buy |
| 200-day EMA: | 32.94 | Buy |
Fortune Brands Innovations Earnings Growth & FBIN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.56 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.
Fortune Brands Innovations Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Collegium Pharmaceutical Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||